ISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world
|
|
- Egbert Hines
- 5 years ago
- Views:
Transcription
1 ISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world
2 Nutrition in Kidney Disease: How to Apply Guidelines to Clinical Practice? T. Alp Ikizler, MD Catherine McLaughlin-Hakim Professor, Medicine Vanderbilt University Medical Center
3 Outline Epidemiology Dietary Protein Intake Metabolic Derangements in CKD Nutritional Support in ESRD
4 Rate of CV Events Rates of Death and CV Events in Patients According to GFR < <15 egfr (ml/min/1.73 m 2 ) Rate of Death From Any Cause* N = 1,120,295 adults; GFR = (estimated) glomerular filtration rate. *Age-standardized rates per 100 person-years; CV event defined as hospitalization or coronary heart disease, heart failure, ischemic stroke, and peripheral arterial disease per 100 person-years. Go et al. N Engl J Med. 2004;351:
5 The death rate of chronic dialysis patients is unacceptably high
6 Complications of CKD and Progression to ESRD CKD Continuum Increasing Severity of Complications CKD Anemia Secondary hyperparathyroidism Dyslipidemia Hypoalbuminemia, malnutrition CVD Uremic Syndrome ESRD GFR (ml/min/1.73 m 2 ) 6
7 Uremic Ultrafiltrate Inhibits Nutrient Intake Modified from Anderstam, Mamoun & Bergstrom JASN 1996
8 Dietary Protein Intake During Progression of Renal Disease Ikizler JASN 1995
9 Protein and Amino Acid Turnover and Waste Products Diet Protein 70 g/d Plasma Proteins 0.5 kg Free Amino Acid Pool 62 g kg g/kg/d Cell Proteins (5.8 kg) Ribosome Amino Proteins Acids Nitrogen Excretion 11.2 g N/d Mitch and Ikizler Handbook of Nutrition in CKD
10 Rationale for Dietary Protein Restriction in CKD Ameliorate Uremic Syndrome (delay initiation) Decrease load on remaining nephrons (preserve RF) Improve proteinuria/albuminuria Additive effect of ACE inhibitors Improve Metabolic Profile Improve insulin Resistance, Acidosis and Oxidative Stress Decrease likelihood of patient death Lack of serious objective reasons for not recommending Adapted from Fouque & Aparicio., Nature Neph. Reviews 2007
11 Progression - mgfr Progression Renal Death Study 1: 585 patients Study 2: 255 patients 11
12 Mean effect: 0.53 ml/min/yr (95% CI, 0.08 to 0.98 ml/min/yr) 12
13 13
14 Dietary Protein Restriction in CKD: Summary There is ample evidence to indicate that dietary protein restriction has several beneficial metabolic benefits. Improve insulin resistance, metabolic acidosis and oxidant stress The overall effects on kidney function seems to be less than expected based on strong animal data and pilot studies. DPI improves proteinuria (15-30%), more so in NS. Additive effect with ACE inhibition. Unable to translate into significant clinical effect Evidence to indicate harm is limited.
15 15
16 Inflammation and Oxidative Stress in Stage II thru IV Chronic Kidney Disease Ramos, LF; et al. Determinants of Protein Oxidation in Stage II thru IV Chronic Kidney Disease; 11/2006
17 Oxidative Stress and Mortality in CKD 100 DMA 16/C16:0 > median 100 Cumulative Survival (%) p < 0.02 DMA 16/C16:0 < median Cumulative Survival (%) Vitamin C >60pmol/L Vitamin C 32 to 60pmol/L Vitamin C <32 pmol/l Observation Time (days) Stenvinkel et al, NDT 19(4): , 976, p = Follow-up Time (months) Deicher, JASN 16: , 1818, 2005
18 A Proposed Mechanism for Uremia- Induced CVD Risk
19 Interventions Targeted at Non-Traditional CV Risk Factors in Uremia Antioxidants Inflammation Uremia Oxidative Stress Endothelial Dysfunction CV Risk Insulin Resistance
20 Tocopherols and Alpha Lipoic Acid Therapy (TALAT) in CKD Trial H 3 C CH 3 O O HO S S OH l l l l l Randomized, double-blind, placebo-controlled trial N = 80 Stage 3-4 CKD patients Tocopherols + -lipoic acid vs. placebo x 8 weeks Primary endpoint, change in F2-isoprostanes Secondary endpoints Inflammatory biomarkers Insulin resistance Endothelial dysfunction Ramos et al JRN 2010
21 Tocopherols and Alpha Lipoic Acid Therapy (TALAT) in CKD Trial Tocopherols + ALA (N = 29) Placebo (N = 30) Age (yrs) 59.3 ± ± 9.0 Gender (% males) 15 (51.7%) 16 (53.3%) Race (% White) 28 (96.6%) 28 (93.3%) Diabetic (%) 16 (55.2%) 16 (53.3%) BMI (kg/m 2 ) 31.9 ± ± 7.7 egfr (ml/min) 38.1 ± ± 14.8 Ramos et al JRN 2010
22 TALAT in CKD Trial F 2 -isoprostane F2-Iso F2-Isoprostanes Baseline Month2 0 Placebo VitE/ALA Ramos et al JRN 2010
23 TALAT in CKD Trial F 2 -isoprostane CRP CRP Placebo VitE/ALA Baseline Month2 Ramos et al JRN 2010
24
25 Multivariable Regression Model for Predictors for Elevated Plasma F 2 - Isoprostanes Variable Coefficient P-value 95% Confidence Interval Age Gender < Race Diabetes Smoking History Estimated GFR Total Cholesterol 1.35 x Serum Albumin BMI Dependent Variable: Plasma F2-Isoprostanes (log 10 transformed) R2 for Model: 0.229
26 Obesity Trends* Among U.S. Adults BRFSS, 1990, 1998, 2007 (*BMI 30, or about 30 lbs. overweight for 5 4 person) >300,000 deaths attributed to obesity No Data <10% 10% 14% 15% 19% 20% 24% 25% 29% 30%
27 27
28
29 Janus: the god of gates, doors, doorways, beginnings and endings. TRANSITION TO ESRD
30 Wasting/Cachexia l AIDS: 5-15% l Cancer: 20-50% l Old age: 5-25% l HD>CKD: 5-30% l >30% muscle loss n n Risk of death Pneumonia
31 Metabolic Paradigm for Uremic Wasting & Potential Targetes for Intervention O Sullivan, AJ, JJ Kelley. Kidney International 2007(71);
32 Schematic representation of causes and manifestations of PEW in Kidney Disease ISRNM Position Paper - Kidney International
33 Protein Balance in Humans Protein synthesis Protein Breakdown n Growth Synthesis>Breakdown n Wasting Breakdown>Synthesis n Strategy: Maximize protein synthesis Minimize protein breakdown
34 IDPN and IDPO lead to significantly higher Whole-Body Protein Anabolism * P<0.05 versus Control, # P<0.05 versus PO
35 * Serum albumin (g/dl) SGA score months Baseline 3-Month 6-Month N=85 N=68 N=61 N=49 N=48 N=42 N=39 N=85 N=49 N=39 Caglar, Hakim, Ikizler Kidney Int, 2002
36
37 AJKD 2005
38 FineS The French Intradialytic Nutrition Evaluation study (FineS) Malnourished MHD patients 182 patients Oral suppl during one year Oral suppl + IDPN during one year Follow-up: two years (treatment period + one year) Visits at day 0 and month 3, 6, 12, 18 and 24
39 FineS Nutritional therapies Oral supplement: 5.4 kcal/kg/d 0.42 g protein/kg/d IDPN : 13.8 kcal/kg/hd (5.9 kcal/kg/d) 0.62 g AA/kg/HD (0.27 g AA/kg/d) Nitrogen supply: standard AA solution Energy supply: 50% standard fat emulsion 50% glucose
40 Results: Nutritional status Serum albumin, g/l NS Months Serum prealbumin, mg/l NS Months Control group IDPN group FineS
41 Patient Survival 1.00 Patient cumulated survival Logrank p = 0.33 NS Days Mean cumulative survival: 77% at 1 yr, 58% at 2 yr Death: Control: n = 36, IDPN: n = 40 FineS
42 What are the significant observations in FINE study? l Oral versus oral and parenteral supplementation does not have any differential effect on survival and on nutritional markers in CHD patients l Equal and adequate amounts of protein and calorie are provided in both groups l Nutritional supplementation does improve nutritional markers l If the targets of dietary protein and energy intake suggested by KDOQI (> 1.2 g/kg/d and > 30 kcal/kg/d, respectively) are achieved.
43 What are the significant observations in FINE study? l These data are confirmatory of the appropriateness of the KDOQI dietary protein and calorie intake guidelines. l Nutritional interventions in general are associated with improved survival in CHD patients. l The study did not include a no-intervention arm.
44 Uremic Protein Energy Wasting Syndrome The etiology of Uremic Protein Energy Wasting Syndrome is multi-factorial (as in most chronic disease states) dietary intake + HD-associated catabolism + Inflammation + Insulin resistance -> wasting in CHD patients -> mortality and morbidity Nutritional Interventions -> convenient and safe; IDPN and Oral supplements can partially reverse the HD-induced catabolism (primarily by replenishing the amino acid pool) Nutritional Interventions -> Potentially can save lives and lead to significant cost savings
Macro- and Micronutrient Homeostasis in the Setting of Chronic Kidney Disease. T. Alp Ikizler, MD Vanderbilt University Medical Center
Macro- and Micronutrient Homeostasis in the Setting of Chronic Kidney Disease T. Alp Ikizler, MD Vanderbilt University Medical Center Nutrition and Chronic Kidney Disease What is the disease itself and
More informationDietary practices in patients with chronic kidney disease not yet on maintenance dialysis: What are the relevant components?
Dietary practices in patients with chronic kidney disease not yet on maintenance dialysis: What are the relevant components? 3 rd International Conference of European Renal Nutrition Working Group of ERA-EDTA
More informationNutritional support in advanced kidney disease: Role of oral and parenteral nutrition. T. Alp Ikizler, MD Vanderbilt University Medical Center
Nutritional support in advanced kidney disease: Role of oral and parenteral nutrition T. Alp Ikizler, MD Vanderbilt University Medical Center Goals To delineate the mechanisms through which wasting syndrome
More informationPr Denis FOUQUE. Department of Nephrology Centre de Recherche en Nutrition Humaine University Claude Bernard Lyon - France
Pr Denis FOUQUE Department of Nephrology Centre de Recherche en Nutrition Humaine University Claude Bernard Lyon - France Observatoire Phosphocalcique, January 2011 1200 36.1 ± 5.0 g/l 1050 900 PEW
More informationNutrition and Renal Disease Update
Nutrition and Renal Disease Update Denis FOUQUE Department of Nephrology Centre de Recherche en Nutrition Humaine University Claude Bernard Lyon - France What have we learned? 1. Chronic kidney disease:
More informationPrevalence of malnutrition in dialysis
ESPEN Congress Cannes 2003 Organised by the Israel Society for Clinical Nutrition Education and Clinical Practice Programme Session: Nutrition and the Kidney Malnutrition and Haemodialysis Doctor Noël
More informationIntradialytic Parenteral Nutrition in Hemodialysis Patients. Hamdy Amin, Pharm.D., MBA, BCNSP Riyadh, Saudi Arabia
Intradialytic Parenteral Nutrition in Hemodialysis Patients Hamdy Amin, Pharm.D., MBA, BCNSP Riyadh, Saudi Arabia Disclosure Information Intradialytic Parenteral Nutrition in Hemodialysis Patients Hamdy
More informationEnd stage renal disease and Protein Energy wasting
End stage renal disease and Protein Energy wasting Dr Goh Heong Keong MBBS,MRCP(UK) www.passpaces.com/kidney.htm Introduction Chronic kidney disease- increasing health burden in many countries. The estimated
More informationEpidemiology, Diagnostic and treatment for Protein Energy Wasting in Dialysis
Epidemiology, Diagnostic and treatment for Protein Energy Wasting in Dialysis Pr Denis FOUQUE Department of Nephrology Centre de Recherche en Nutrition Humaine University Claude Bernard Lyon - France ESRD
More informationMalnutrition in advanced CKD
Malnutrition in advanced CKD Malnutrition Lack of proper nutrition, caused by not having enough to eat, not eating enough of the right things or being unable to use the food that one does eat Jessica Stevenson
More informationTO EAT OR NOT TO EAT DURING HEMODIALYSIS TREATMENT?
TO EAT OR NOT TO EAT DURING HEMODIALYSIS TREATMENT? Rana G. Rizk, PhD, MPH, LD Maastricht University, The Netherlands November, 2017 Learning objectives Review the evidence behind benefits and concerns
More informationNutrition Dilemmas, Controversies & Issues CHRONIC KIDNEY DISEASE (CKD)
Nutrition Dilemmas, Controversies & Issues CHRONIC KIDNEY DISEASE (CKD) Objectives To discuss the role of nutrition in clinical outcomes of chronic kidney disease (CKD) To discuss and update on the nutrition
More informationSUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.
Supplementary Figure S1. Cohort definition flow chart. Supplementary Table S1. Baseline characteristics of study population grouped according to having developed incident CKD during the follow-up or not
More informationTABLE OF CONTENTS T-1. A-1 Acronyms and Abbreviations. S-1 Stages of Chronic Kidney Disease (CKD)
A-1 Acronyms and Abbreviations TABLE OF CONTENTS S-1 Stages of Chronic Kidney Disease (CKD) Chapter 1: Nutrition Assessment Charts, Tables and Formulas 1-2 Practical Steps to Nutrition Assessment Adult
More informationNutritional Management of Criticallly Ill Patients with Acute Kidney Injury
Nutritional Management of Criticallly Ill Patients with Acute Kidney Injury 3 rd International Conference of European Renal Nutrition Working Group of ERA-EDTA T. Alp Ikizler, MD Catherine McLaughlin-Hakim
More informationLLL Session - Nutritional support in renal disease
ESPEN Congress Leipzig 2013 LLL Session - Nutritional support in renal disease Peritoneal dialysis D. Teta (CH) Nutrition Support in Patients undergoing Peritoneal Dialysis (PD) Congress ESPEN, Leipzig
More informationAspetti nutrizionali nel paziente in emodialisi cronica
Aspetti nutrizionali nel paziente in emodialisi cronica Enrico Fiaccadori enrico.fiaccadori@unipr.it Università degli Studi di Parma Agenda Diagnosis of protein-energy wasting (PEW) in ESRD on HD Epidemiology
More informationCardiovascular Mortality: General Population vs ESRD Dialysis Patients
Cardiovascular Mortality: General Population vs ESRD Dialysis Patients Annual CVD Mortality (%) 100 10 1 0.1 0.01 0.001 25-34 35-44 45-54 55-64 66-74 75-84 >85 Age (years) GP Male GP Female GP Black GP
More informationMorbidity & Mortality from Chronic Kidney Disease
Morbidity & Mortality from Chronic Kidney Disease Dr. Lam Man-Fai ( 林萬斐醫生 ) Honorary Clinical Assistant Professor MBBS, MRCP, FHKCP, FHKAM, PDipID (HK), FRCP (Edin, Glasg) Hong Kong Renal Registry Report
More informationNutritional Cases with CKD HEMODIALYSIS
Nutritional Cases with CKD HEMODIALYSIS S. Muge DEGER, MD, FISN Yuksek Ihtisas University Faculty of Medicine, Koru Hospital Department of Nephrology Ankara, TURKEY CASE-1 BC, is a 60- year- old Caucasian
More informationNeed for specialized nutrition to prevent accelerated muscle loss in CKD
Need for specialized nutrition to prevent accelerated muscle loss in CKD Prof. Daniel Teta Head Service of Nephrology Hôpital du Valais, Sion CHUV, Université de Lausanne 21st September 2017 Conflicts
More informationPredicting and changing the future for people with CKD
Predicting and changing the future for people with CKD I. David Weiner, M.D. Co-holder, C. Craig and Audrae Tisher Chair in Nephrology Professor of Medicine and Physiology and Functional Genomics University
More informationGuidelines for the Management of Nutrition
S 42 Indian Journal of Nephrology Introduction Protein-energy malnutrition (PEM) is very common among patients with advanced chronic kidney disease (CKD). In the Indian scenario, where malnutrition is
More informationIpovitaminosi D e metabolismo calcio-fosforo in dialisi peritoneale. Maurizio Gallieni Università degli Studi di Milano
Ipovitaminosi D e metabolismo calcio-fosforo in dialisi peritoneale Maurizio Gallieni Università degli Studi di Milano G Ital Nefrol 2018 - ISSN 1724-5990 Nutrients 2017, 9, 328 Vitamin D deficiency (
More informationIntradialytic Parenteral Nutrition. Description
Subject: Intradialytic Parenteral Nutrition Page: 1 of 9 Last Review Status/Date: September 2015 Intradialytic Parenteral Nutrition Description Intradialytic parenteral nutrition (IDPN) is the infusion
More informationNutrition Assessment in CKD
Nutrition Assessment in CKD Shiaw-Wen Chien, MD, EMBA Division of Nephrology, Department of Medicine, Tungs Taichung MetroHarbor Hospital Taichung, Taiwan September 10, 2017 Outline Introduction Composite
More informationJOSHUA K. KAYIMA INTERLINKING CARDIOVASCULAR DISEASE, CHRONIC KIDNEY DISEASE, AND OBESITY
INTERLINKING CARDIOVASCULAR DISEASE, CHRONIC KIDNEY DISEASE, AND OBESITY JOSHUA K. KAYIMA ASSOCIATE PROFESSOR DEPT. OF CLINICAL MEDICINE AND THERAPEUTICS UNIVERSITY OF NAIROBI Introduction According to
More informationIntradialytic Parenteral Nutrition
Intradialytic Parenteral Nutrition Policy Number: 8.01.44 Last Review: 8/2014 Origination: 8/2014 Next Review: 8/2015 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for
More informationNutrition in hemodialysis patients with focus on Intradialytic Parenteral Nutrition (IDPN)
Nutrition in hemodialysis patients with focus on Intradialytic Parenteral Nutrition (IDPN) Enrico Fiaccadori enrico.fiaccadori@unipr.it Acute and Chronic Renal Failure Unit Medicine & Surgery Dept. Parma
More informationAssessment and Monitoring of Nutritional Status in Chronic Kidney Disease Patients
Divisions of Baxter Novum and Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet Assessment and Monitoring of Nutritional Status in Chronic Kidney Disease
More informationObesity in the pathogenesis of chronic disease
Portoroz October 16th 2013 Obesity in the pathogenesis of chronic disease Rocco Barazzoni University of Trieste Department of Medical, Surgical and Health Sciences Obesity Trends* Among U.S. Adults BRFSS,
More informationTrial to Reduce. Aranesp* Therapy. Cardiovascular Events with
Trial to Reduce Cardiovascular Events with Aranesp* Therapy John J.V. McMurray, Hajime Uno, Petr Jarolim, Akshay S. Desai, Dick de Zeeuw, Kai-Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis,
More informationThe Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009
The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,
More informationPrevalence of anemia and cardiovascular diseases in chronic kidney disease patients: a single tertiary care centre study
International Journal of Advances in Medicine Sathyan S et al. Int J Adv Med. 2017 Feb;4(1):247-251 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20170120
More informationin CKD Patients Associate Professorr of Medicine Iran University of Medical Sciences
Management of Nutrition in CKD Patients Shokoufeh Sa avaj MD Associate Professorr of Medicine Iran University of Medical Sciences Introduction Dietary factors may have an effect on the progression of kidney
More informationBy; Ashraf El Houfi MD MS (pulmonology) MRCP (UK) FRCP (London) EDIC Consultant ICU Dubai Hospital
By; Ashraf El Houfi MD MS (pulmonology) MRCP (UK) FRCP (London) EDIC Consultant ICU Dubai Hospital Introduction The significance of nutrition in hospital setting (especially the ICU) cannot be overstated.
More informationChronic Kidney Disease Clinical Practice Guidelines: Implementation Strategies
Chronic Kidney Disease Clinical Practice Guidelines: Implementation Strategies Guidelines International Network November 2, 2004 The National Kidney Foundation The Mission of the National Kidney Foundation
More informationAddressing Chronic Kidney Disease in People with Multiple Chronic Conditions
Addressing Chronic Kidney Disease in People with Multiple Chronic Conditions Andrew S Narva, MD Na/onal Kidney Disease Educa/on Program U.S. Department of Health and Human Services National Institute of
More informationMagnetic resonance imaging, image analysis:visual scoring of white matter
Supplemental method ULSAM Magnetic resonance imaging, image analysis:visual scoring of white matter hyperintensities (WMHI) was performed by a neuroradiologist using a PACS system blinded of baseline data.
More informationEffects of Kidney Disease on Cardiovascular Morbidity and Mortality
Effects of Kidney Disease on Cardiovascular Morbidity and Mortality Joachim H. Ix, MD, MAS Assistant Professor in Residence Division of Nephrology University of California San Diego, and Veterans Affairs
More informationInterventions to reduce progression of CKD what is the evidence? John Feehally
Interventions to reduce progression of CKD what is the evidence? John Feehally Interventions to reduce progression of CKD what is the evidence? CHALLENGES Understanding what we know. NOT.what we think
More informationSUBJECT INDEX. Tvedegaard, E., 20. Ulerich, L., E1 (July) Wapensky, T., 45 Warner, J., 116 Warsaba, D., 52
268 Supasyndh, O., 134 Suraci, C., 208 Tatangelo, P., 208 Tavares, I., 157 Tozzo, C., 208 Tvedegaard, E., 20 Ulerich, L., E1 (July) Wapensky, T., 45 Warner, J., 116 Warsaba, D., 52 Wells, L.M., 26 Winkler,
More informationLab Values Explained. working at full strength. Other possible causes of an elevated BUN include dehydration and heart failure.
Patient Education Lab Values Explained Common Tests to Help Diagnose Kidney Disease Lab work, urine samples and other tests may be given as you undergo diagnosis and treatment for renal failure. The test
More information1. Reggie J. Divina, M.D. (1) 2. Fe S. Felicilda, M.D., DPBCN (1,2) 3. Rufino E. Chan, M.D. (1) 4. Luisito O. Llido, M.D.
82 TITLE: Nutritional status of hemodialysis patients in the Philippines: a cross sectional survey in four out- patient dialysis centers Submitted: January 10, 2010 Posted: August 30, 2010 AUTHOR(S) 1.
More informationAGING KIDNEY IN HIV DISEASE
AGING KIDNEY IN HIV DISEASE Michael G. Shlipak, MD, MPH Professor of Medicine, Epidemiology and Biostatistics, UCSF Chief, General Internal Medicine, San Francisco VA Medical Center Kidney, Aging and HIV
More informationegfr > 50 (n = 13,916)
Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according
More informationAccelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus
Kidney International, Vol. 68 (2005), pp. 2368 2374 Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus LARA B. PUPIM, OLOF HEIMBÜRGER, ABDUL RASHID QURESHI, T.
More informationAnalytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health
Analytical Methods: the Kidney Early Evaluation Program (KEEP) 2000 2006 Database Design and Study Participants The Kidney Early Evaluation program (KEEP) is a free, community based health screening program
More informationGuidelines elderly population with CKD 3-5: Nutrition
Guidelines elderly population with CKD 3-5: Nutrition Dr.P.Bernaert, nefrologie, AZ Maria Middelares Gent AZ MM - SJ Belgium Notion:Nutritional status is a strong predictor of survival in patients starting
More informationIntradialytic Parenteral Nutrition
Intradialytic Parenteral Nutrition Policy Number: 8.01.44 Last Review: 8/2017 Origination: 8/2014 Next Review: 8/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for
More informationDr. Liliana Garneata Assistant Professor of Nephrology Dr Carol Davila Teaching Hospital of Nephrology, Bucharest, Romania
Dr. Liliana Garneata Assistant Professor of Nephrology Dr Carol Davila Teaching Hospital of Nephrology, Bucharest, Romania Nutritional management of CKD: Key-role of ketoanalogues with low protein diets
More informationOutline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Other criteria for starting dialysis GUIDELINES
Date written: September 2004 Final submission: February 2005 Other criteria for starting dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationTREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009
TREAT THE KIDNEY TO SAVE THE HEART Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009 1 ESRD Prevalent Rates in 1996 per million population December
More informationCan Oral Supplementation with a Collagen-Casein-Based Liquid Protein Improve Serum Albumin Levels in Hemodialysis Patients?
Can Oral Supplementation with a Collagen-Casein-Based Liquid Protein Improve Serum Albumin Levels in Hemodialysis? Ann Pittaoulis, RD, LDN; Evelyn Phillips, MS, RD, LDN A. Pittaoulis is with Belmont Court
More informationCardiovascular Diseases in CKD
1 Cardiovascular Diseases in CKD Hung-Chun Chen, MD, PhD. Kaohsiung Medical University Taiwan Society of Nephrology 1 2 High Prevalence of CVD in CKD & ESRD Foley RN et al, AJKD 1998; 32(suppl 3):S112-9
More informationCardiovascular Complications Of Chronic Kidney Disease. Dr Atir Khan Consultant Physician Diabetes & Endocrinology West Wales Hospital, Carmarthen
Cardiovascular Complications Of Chronic Kidney Disease Dr Atir Khan Consultant Physician Diabetes & Endocrinology West Wales Hospital, Carmarthen Markers of kidney dysfunction Raised Albumin / Creatinine
More informationCardiovascular Risk Reduction in Kidney Transplant Recipients
Cardiovascular Risk Reduction in Kidney Transplant Recipients Rainer Oberbauer R.O. AUG 2010 CV Mortality in ESRD compared to the general population R.O.2/32 Modified from Foley et al. AJKD 32 (suppl3):
More informationDOWNLOAD OR READ : NUTRITION DURING DIALYSIS TREATMENT PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : NUTRITION DURING DIALYSIS TREATMENT PDF EBOOK EPUB MOBI Page 1 Page 2 nutrition during dialysis treatment nutrition during dialysis treatment pdf nutrition during dialysis treatment
More informationTherapeutic golas in the treatment of CKD-MBD
Therapeutic golas in the treatment of CKD-MBD Hemodialysis clinic Clinical University Center Sarajevo Bantao, 04-08.10.2017, Sarajevo Abbvie Satellite symposium 06.10.2017 Chronic Kidney Disease Mineral
More information17 th Annual Meeting of JSHDF, Sept 3-4, 2011
17 th Annual Meeting of JSHDF, Sept 3-4, 2011 Sug Kyun Shin 1, JY Moon 2, SW Han 3, DH Yang 4, SH Lee 2, HC Park 5, JK Kim 6 and YI Jo 7 1 Nephrology, NHIC Ilsan Hospital, 2 Kyunghee University Hospital
More informationHTA ET DIALYSE DR ALAIN GUERIN
HTA ET DIALYSE DR ALAIN GUERIN Cardiovascular Disease Mortality General Population vs ESRD Dialysis Patients 100 Annual CVD Mortality (%) 10 1 0.1 0.01 0.001 25-34 35-44 45-54 55-64 66-74 75-84 >85 Age
More informationAn update on the obesity epidemics in CKD and in ESRD. Does it really matter?
EURECA-m 2011 An update on cutting-edge Cardiovascular and Renal Medicine themes. An update on the obesity epidemics in CKD and in ESRD. Does it really matter? Francesca Mallamaci BMI>30 25 Ireland 20
More informationAdvances in Practice. Effect of Peridialytic Protein Bar Supplementation Among Malnourished Hemodialysis Patients
Advances in Practice Effect of Peridialytic Protein Bar Supplementation Among Malnourished Hemodialysis Patients Corresponding Author: Vasudevan Preethi MSc Clinical Nutrition Student, Department of Clinical
More informationCKD and CVD. Jamal Salameh, MD, FACP, FASN First Coast Nephrology
CKD and CVD Jamal Salameh, MD, FACP, FASN First Coast Nephrology An Epidemic of Kidney Disease Prevalence CKD stages 1-4 10% 1988-94 13% 1999-2004 Coresh, JAMA 298:2038, 2007 Stage 5: GFR
More informationNutrition in end-stage renal disease
Kidney International, Vol. 50 (1996), pp. 343 357 PERSPECTIVES IN CLINICAL NEPHROLOGY Nutrition in end-stage renal disease Despite substantial improvements in the science and technology of renal replacement
More informationDiabetic Kidney Disease in the Primary Care Clinic
Diabetic Kidney Disease in the Primary Care Clinic Jess Wheeler, DO Nephrology 2015 Outline: 1. CKD/DKD is a growing problem 2. Diagnosis of Chronic Kidney Disease (CKD) 3. Diagnosis of Diabetic Kidney
More informationPRE-DIALYSIS CARE IN CHRONIC KIDNEY DISEASE PATIENTS DR O. A ADEJUMO MBBS, FWACP, FMCP
PRE-DIALYSIS CARE IN CHRONIC KIDNEY DISEASE PATIENTS DR O. A ADEJUMO MBBS, FWACP, FMCP OUTLINE INTRODUCTION BURDEN OF CKD DEFINITION OF PRE-DIALYSIS CARE (PDC) GOALS OF PDC IN CKD COMPONENTS OF PDC ADVANTAGES
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More informationNutrition in Acute Kidney Injury Enrico Fiaccadori
Nutrition in Acute Kidney Injury Enrico Fiaccadori Nephrology Dept. Parma University Medical School Parma, Italy Diagnosis, epidemiology and prognostic impact of proteinenergy wasting (PEW) in AKI Pathogenetic
More informationCARDIO-RENAL SYNDROME
CARDIO-RENAL SYNDROME Luis M Ruilope Athens, October 216 DISCLOSURES: ADVISOR/SPEAKER for Astra-Zeneca, Bayer, BMS, Daiichi-Sankyo, Esteve, GSK Janssen, Lacer, Medtronic, MSD, Novartis, Pfizer, Relypsa,
More informationCase Study: Chronic Kidney Disease
Taylor Zwimpfer Joan Rupp Nutrition 409 23 September 2014 Case Study: Chronic Kidney Disease 1. Kidneys act to maintain the balance of fluids, electrolytes and organic solutes in the body through filtration
More informationPediatric Nutrition and Kidney Disease
Pediatric Nutrition and Kidney Disease Loai Eid, MD, MSHS, FAAP Consultant Pediatric Nephrologist Pediatric Nephrology & Hypertension Division Chief Dubai Hospital - DHA 26 th October, 2017 Objectives
More informationPotential Impact of Nutritional Intervention on End-Stage Renal Disease Hospitalization, Death, and Treatment Costs
ORIGINAL RESEARCH Potential Impact of Nutritional Intervention on End-Stage Renal Disease Hospitalization, Death, and Treatment Costs Eduardo Lacson, Jr., MD,* T. Alp Ikizler, MD, J. Michael Lazarus, MD,*
More informationImpact of L-carnitine Pretreatment on Intravenous Iron Administration-induced Oxidative Stress and Inflammatory Response in Patients with CKD
Impact of L-carnitine Pretreatment on Intravenous Iron Administration-induced Oxidative Stress and Inflammatory Response in Patients with CKD Dr. Zaher Armaly Nephrology Department Nazareth EMMS Hospital
More informationEffect of Saxagliptin on Renal Outcomes in the SAVOR TIMI- 53 study- Appendixes:
Effect of Saxagliptin on Renal Outcomes in the SAVOR TIMI- 53 study- Appendixes: Appendix Table 1: Number and % of patients at the saxagliptin and placebo arms, according to egfr and on treatment ACR groups
More informationReducing proteinuria
Date written: May 2005 Final submission: October 2005 Author: Adrian Gillin Reducing proteinuria GUIDELINES a. The beneficial effect of treatment regimens that include angiotensinconverting enzyme inhibitors
More informationESPEN Congress Vienna Nutritional implications of renal replacement therapy in ICU Nutritional support - how much nitrogen? W.
ESPEN Congress Vienna 2009 Nutritional implications of renal replacement therapy in ICU Nutritional support - how much nitrogen? W. Druml (Austria) Nutritional Implications of Renal Replacement Therapy
More informationFigure 1 LVH: Allowed Cost by Claim Volume (Data generated from a Populytics analysis).
Chronic Kidney Disease (CKD): The New Silent Killer Nelson Kopyt D.O. Chief of Nephrology, LVH Valley Kidney Specialists For the past several decades, the health care needs of Americans have shifted from
More informationHYPERTENSION GUIDELINES WHERE ARE WE IN 2014
HYPERTENSION GUIDELINES WHERE ARE WE IN 2014 Donald J. DiPette MD FACP Special Assistant to the Provost for Health Affairs Distinguished Health Sciences Professor University of South Carolina University
More informationOutline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationIntradialytic Parenteral Nutrition
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationMalnutrition and inflammation in peritoneal dialysis patients
Kidney International, Vol. 64, Supplement 87 (2003), pp. S87 S91 Malnutrition and inflammation in peritoneal dialysis patients PAUL A. FEIN, NEAL MITTMAN, RAJDEEP GADH, JYOTIPRAKAS CHATTOPADHYAY, DANIEL
More informationALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)
1 RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) 6 / 5 / 1006-1 2 Introduction Hypertension is the second most common cause of end-stage
More informationNutritional considerations in the dialysis population: from malnutrition to obesity
Nutritional considerations in the dialysis population: from malnutrition to obesity Jessica Stevenson Senior Renal Dietitian, St George Hospital PhD Candidate, The University of Sydney Presentation outline:
More informationDr. Mehmet Kanbay Department of Medicine Division of Nephrology Istanbul Medeniyet University School of Medicine Istanbul, Turkey.
The uric acid dilemma: causal risk factor for hypertension and CKD or mere bystander? Mehmet Kanbay, Istanbul, Turkey Chairs: Anton H. van den Meiracker, Rotterdam, The Netherlands Claudia R.C. Van Roeyen,
More informationNutrition Management of Children on Dialysis
Nutrition Management of Children on Dialysis Loai Eid, MD, MSHS, FAAP Consultant Pediatric Nephrologist Pediatric Nephrology & Hypertension Division Chief Dubai Hospital - DHA 26 th October, 2017 Learning
More informationCardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center
Cardiovascular Disease in CKD Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Objectives Describe prevalence for cardiovascular disease in CKD
More informationChronic kidney disease (CKD) has received
Participant Follow-up in the Kidney Early Evaluation Program (KEEP) After Initial Detection Allan J. Collins, MD, FACP, 1,2 Suying Li, PhD, 1 Shu-Cheng Chen, MS, 1 and Joseph A. Vassalotti, MD 3,4 Background:
More informationA: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups
A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were
More informationChronic Kidney Disease is Associated with Cognitive Decline: the Northern Manhattan Study (NOMAS) Seattle VA Chief of Medicine Rounds June 9, 2009
Chronic Kidney Disease is Associated with Cognitive Decline: the Northern Manhattan Study (NOMAS) Seattle VA Chief of Medicine Rounds June 9, 2009 Minesh Khatri Internal Medicine R2 Background Patients
More informationE.Ritz Heidelberg (Germany)
Predictive capacity of renal function in cardiovascular disease E.Ritz Heidelberg (Germany) If a cure is not achieved, the kidneys will pass on the disease to the heart Huang Ti Nei Ching Su Wen The Yellow
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and
More informationDapagliflozin and Outcomes in Patients with Peripheral Artery Disease: Insights from DECLARE-TIMI 58
Dapagliflozin and Outcomes in Patients with Peripheral Artery Disease: Insights from DECLARE-TIMI 58 Marc P. Bonaca MD MPH for the DECLARE TIMI 58 Investigators American College of Cardiology March 2019
More informationDiseases of the Renal System
Diseases of the Renal System Chapter 20 1 2 Kidneys - Anatomy Regulatory and metabolic functions Nephron - functional unit; approx. 1.2 million in each kidney Glomerulus within Bowman s capsule Afferent
More informationLow-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies
Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies Mohsen Mazidi 1, Niki Katsiki 2, Dimitri P. Mikhailidis 3, Maciej Banach
More informationSAMPLE. Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process. Chapter 1
Chapter 1 Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process This guide follows the steps of the Nutrition Care Process (NCP) nutrition assessment, nutrition diagnosis, nutrition
More informationObjectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives
The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA
More informationComplete Medical History
Lab Results for Ben Greenfield Last Test Date: Your medical history is not complete. Complete Medical History Complete Medical History What's Next Blood Draw Blood draw scheduled Complete your medical
More information